Andere talen Golden Biotechnology Corporation

Aandelen

4132

TW0004132006

slotkoers Taipei Exchange Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28,7 ^TWD	-0,35%		+0,53%	-26,88%

18/01	Golden Biotechnology Corp. onthult de bevindingen van haar Fase II klinische studie waarin Antroquinonol wordt onderzocht	CI
2023	Golden Biotechnology Corporation rapporteert resultaten voor het halfjaar dat eindigde op 30 juni 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ASCO GI 2024, Golden Biotech's Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients	19/01
Golden Biotechnology Corp. Unveils the Findings of Its Phase II Clinical Trial Investigating Antroquinonol	18/01
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	14-08-23
Golden Biotech Announces Positive Results with Longer Survival Compared with Standard Treatments from Interim Analysis of Phase 2 Trial for Antroquinonol as 1st Line Treatment for Stage 4 Metastatic Pancreatic Cancer	05-05-23
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	28-04-23
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	12-08-22
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	28-04-22
Golden Biotechnology Corporation Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients	07-01-22
Golden Biotechnology Corporation Receives Antroquinonol Oral Covid-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe Covid-19 Patients	16-09-21
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	16-08-21
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	30-03-21
GoldenBiotech's New Drug Antroquinonol Trial Receives Positive Response from DMC Review and Licenses for 4 Countries	04-02-21
Golden Biotechnology Corp. Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia	26-11-20
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	11-08-20
Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA	02-07-20
Golden Biotechnology Corp. Announces it's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA	01-07-20
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	05-04-20
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	06-08-19
Golden Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	02-04-19
Golden Biotechnology Corporation(GTSM:4132) added to S&P Global BMI Index	24-09-18

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Golden Biotechnology Corporation

Aandelen

4132

TW0004132006

Andere talen

Filters